ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.5873
-0.0002 (-0.03%)
At close: Apr 2, 2025, 4:00 PM
0.6089
+0.0216 (3.68%)
After-hours: Apr 2, 2025, 7:50 PM EDT

ZyVersa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
22514--
Market Cap Growth
-47.34%-47.34%-66.90%---
Enterprise Value
-02318--
Last Close Price
0.591.069.00549.50--
PB Ratio
0.170.290.430.14--
Debt / Equity Ratio
--0.000.00-0.71-0.43
Quick Ratio
0.140.140.310.720.020.02
Current Ratio
0.150.150.330.780.060.05
Return on Equity (ROE)
-96.10%-96.10%-177.53%-32.53%--
Return on Assets (ROA)
-26.74%-26.74%-12.82%-14.45%-531.56%-
Return on Capital (ROIC)
-58.27%-58.27%-16.26%-18.00%--
Earnings Yield
-615.93%-378.83%-2083.02%-99.05%--
Buyback Yield / Dilution
-1038.49%-1038.49%99.58%-849.06%-3478.59%-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q